Search research articles
Contact Us
Filters
Showing results (131-140 of 177) with videos related to
Page
of 18
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)
|
December 11, 2019
A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index
Jason A Zell, Christine E McLaren, Timothy R Morgan, et al.
Journal of Hepatology
|
July 19, 2015
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance
Thomas R O'Brien, Ruth M Pfeiffer, Ashley Paquin, et al.
Digestive Diseases and Sciences
|
December 11, 2024
Access to Evaluation for Liver Transplantation in the Veterans Health Administration
Vera Yakovchenko, Michael F Chang, Ruben Hernaez, et al.
Gastroenterology
|
December 7, 2010
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C
Anna S Lok, James E Everhart, Elizabeth C Wright, et al.
The New England Journal of Medicine
|
December 5, 2008
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon
Adrian M Di Bisceglie, Mitchell L Shiffman, Gregory T Everson, et al.
Digestive Diseases and Sciences
|
April 14, 2024
Organizational and Implementation Factors Associated with Cirrhosis Care in the Veterans Health Administration
Heather McCurdy, Anna Nobbe, Dawn Scott, et al.
Hepatology (Baltimore, Md.)
|
July 28, 2006
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial
Chihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 14, 2007
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial
Anna S F Lok, James E Everhart, Raymond T Chung, et al.
Gastroenterology
|
October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease
Anna S Lok, Leonard B Seeff, Timothy R Morgan, et al.
Gastroenterology
|
September 22, 2009
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C
Marc G Ghany, Anna S F Lok, James E Everhart, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 177) with videos related to
Sort By:
Page
of 18
Cancer Prevention Research (Philadelphia, Pa.)
|
December 11, 2019
A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index
Jason A Zell, Christine E McLaren, Timothy R Morgan, et al.
Journal of Hepatology
|
July 19, 2015
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance
Thomas R O'Brien, Ruth M Pfeiffer, Ashley Paquin, et al.
Digestive Diseases and Sciences
|
December 11, 2024
Access to Evaluation for Liver Transplantation in the Veterans Health Administration
Vera Yakovchenko, Michael F Chang, Ruben Hernaez, et al.
Gastroenterology
|
December 7, 2010
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C
Anna S Lok, James E Everhart, Elizabeth C Wright, et al.
The New England Journal of Medicine
|
December 5, 2008
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon
Adrian M Di Bisceglie, Mitchell L Shiffman, Gregory T Everson, et al.
Digestive Diseases and Sciences
|
April 14, 2024
Organizational and Implementation Factors Associated with Cirrhosis Care in the Veterans Health Administration
Heather McCurdy, Anna Nobbe, Dawn Scott, et al.
Hepatology (Baltimore, Md.)
|
July 28, 2006
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial
Chihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 14, 2007
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial
Anna S F Lok, James E Everhart, Raymond T Chung, et al.
Gastroenterology
|
October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease
Anna S Lok, Leonard B Seeff, Timothy R Morgan, et al.
Gastroenterology
|
September 22, 2009
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C
Marc G Ghany, Anna S F Lok, James E Everhart, et al.
Page
of 18